Bio

Dr. Hannah graduated from Kansas City University of Medicine & Biosciences. He then completed a residency in Internal Medicine at the University of Kansas and a fellowship in Hospice & Palliative Medicine at Stanford University before joining as faculty at Stanford. His clinical practice includes both inpatient palliative care consultation as well as ambulatory care in palliative medicine. His research and educational interests include symptom management and utilizing media to grow palliative care services and education.

Clinical Focus

  • Palliative Medicine
  • Hospice and Palliative Medicine

Academic Appointments

Boards, Advisory Committees, Professional Organizations

  • Physician Member, American Academy of Hospice and Palliative Medicine (2016 - Present)

Professional Education

  • Board Certification: American Board of Internal Medicine, Hospice and Palliative Medicine (2018)
  • Residency: University of Kansas School of Medicine (2016) KS
  • Fellowship: Stanford University Hospice and Palliative Care Fellowship CA
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2016)
  • Medical Education: Kansas City University of Medicine and Biosciences (2013) MO

Contact

  • Academic
    University - Academic staff Department: Med/Primary Care and Population Health Position: Clinical Assistant Professor
  • Clinical Stanford Palliative Medicine 300 Pasteur Dr Rm HC005 MC 5277 Stanford, CA 94305 (650) 497-6853 (fax)
  • Clinical Emeryville Multispecialty Clinic 5800 Hollis St Emeryville, CA 94608 (510) 806-2548 (fax)
  • Clinical Stanford Health Care Radiation Oncology at Pleasanton 5725 W Las Positas Blvd Ste 100B Pleasanton, CA 94588 (650) 497-7056 (fax)

Additional Info

  • Mail Code: 5475

All Publications

  • Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Quality Improvement Initiative. Oncology nursing forum Vega, C., Whitney, R. L., Hannah, J., Smith, G. 2022; 49 (3): 233-241

    Abstract

    OBJECTIVES: To evaluate the effects of virtual reality (VR) on symptom distress, such as depression, anxiety, and pain, experienced by individuals receiving allogeneic hematopoietic stem cell transplantation.SAMPLE & SETTING: 20 participants aged 19-70 years (median age of 56.5 years) who were hospitalized in an academic setting received as many as two sessions of VR per week for two weeks.METHODS & VARIABLES: Before and after each session, participants completed the revised Edmonton Symptom Assessment Scale (ESAS-r) to evaluate their symptoms. Paired t tests were later conducted.RESULTS: VR sessions showed significant improvement in 8 of the 10 symptoms addressed in ESAS-r.IMPLICATIONS FOR NURSING: VR can improve symptoms in patients following hematopoietic stem cell transplantation in a hospital setting, provide a low-cost intervention to treat symptoms, and support future investigations exploring how VR affects prolonged hospitalizations related to distressing symptoms.

    View details for DOI 10.1188/22.ONF.233-241

    View details for PubMedID 35446838